Cyteir Therapeutics, Inc.
NASDAQ:CYT
3.02 (USD) • At close March 15, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||||
| Net Income
| -3.532 | -8.404 | -12.486 | -8.793 | -11.045 | -12.121 | -14.102 | -11.815 | -11.704 | -11.295 | -7.312 | -5.36 | -5.036 | -4.498 | -5.929 |
| Depreciation & Amortization
| 0.11 | 0.108 | 0.15 | 0.17 | 0.17 | 0.169 | 0.159 | 0.14 | 0.125 | 0.111 | 0.103 | 0.095 | 0.107 | 0.082 | 0.067 |
| Deferred Income Tax
| -1.64 | -0.319 | 0 | 0 | 0 | 0 | 0 | -2.15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0.599 | 0.776 | 1.042 | 0.869 | 1.193 | 1.365 | 1.255 | 1.133 | 1.072 | 0.772 | 0.488 | 0.136 | 0.135 | 0.107 | 0.089 |
| Change In Working Capital
| -1.733 | 3.371 | 0.362 | 0.681 | -3.038 | -0.537 | 0.366 | 0.925 | -2.423 | 3.301 | 0.347 | -0.023 | 0.2 | 0.171 | 1.118 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| -0.831 | 0.665 | -0.454 | -0.538 | -1.947 | 0.115 | 1.713 | -1.549 | -0.109 | 1.365 | 0.331 | 0.714 | -0.054 | -0.155 | 0.522 |
| Other Working Capital
| -0.902 | 2.706 | 0.454 | 1.219 | -1.091 | -0.652 | -1.347 | 2.474 | -2.314 | 1.936 | 0.016 | -0.737 | 0.254 | 0.326 | 0.596 |
| Other Non Cash Items
| 1.64 | 0.319 | 0.765 | 0.156 | 0.153 | 0.244 | 0.154 | 2.15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Cash Flow
| -4.556 | -4.149 | -10.167 | -6.917 | -12.567 | -10.88 | -12.168 | -9.617 | -12.93 | -7.111 | -6.374 | -5.152 | -4.594 | -4.138 | -4.655 |
| Investing Activities: | |||||||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | -0.302 | -0.01 | -0.111 | -0.191 | -0.503 | -0.394 | -0.114 | -0.178 | -0.052 | -0.244 | -0.013 | -0.541 |
| Acquisitions Net
| 0 | 0.153 | 0.15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 0 | 0.153 | 0.15 | -0.302 | -0.01 | -0.111 | -0.191 | -0.503 | -0.394 | -0.114 | -0.178 | -0.052 | -0.244 | -0.013 | -0.541 |
| Financing Activities: | |||||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0.164 | 0.428 | 0.061 | 0.064 | 0.071 | 0.005 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | 0 | 0.042 | 0.083 | 0 | 0.005 | 0.019 | 0 | 0.015 | 0.122 | 0.08 | 1.137 | 0.289 | 0.001 | 0 |
| Financing Cash Flow
| 0.164 | 0.428 | 0.103 | 0.147 | 0.071 | 0.005 | 0.019 | 0 | 0.015 | 0.122 | 0.08 | 1.137 | 0.289 | 0.001 | 0 |
| Other Information: | |||||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0.302 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -4.392 | -3.568 | -9.914 | -6.77 | -12.506 | -10.986 | -12.34 | -10.099 | 1.185 | 114.442 | 73.257 | -4.067 | -4.549 | -4.15 | -5.196 |
| Cash At End Of Period
| 129.503 | 133.895 | 137.463 | 147.377 | 154.147 | 166.653 | 177.639 | 189.979 | 200.078 | 198.893 | 84.451 | 11.194 | 15.261 | 19.81 | 23.96 |